Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
2 天
Best Life on MSNNew Drug Can Reduce COVID Risk By 67%, Research Shows—If You Take It at This TimeMedicines like Paxlovid exist to treat COVID in high-risk people by preventing the virus from multiplying if taken at the ...
Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.
Researchers from the University of Colorado Anschutz Medical Campus studied a new method to deliver antibiotics, specifically ...
A newer class of diabetes drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors has been linked to a rare but ...
Zydus Lifesciences has received USFDA approval to manufacture its generic version of Methenamine Hippurate tablets for ...
The child was rushed out of the Women In Need (WIN) shelter on Glenwood Road near Schenectady Ave. in East Flatbush about 8 a.m. Tuesday.
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...
Post-acute neuropsychiatric symptoms triggered by COVID-19 could raise the long-term use of multiple psychoactive drugs in LTC residents.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果